Clinical trial NCT01274091: Gene - Diet Interactions
Official title: Gene-diet Interactions
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Insulin Sensitivity
Keywords: Gene-diet interaction
PPARgamma gene
Pro12Ala
Fatty acids
Dietary modification
Insulin sensitivity
Glucose metabolism
Lead sponsor: University of Eastern Finland
Sponsor class: OTHER
Collaborators: name: Kuopio University Hospital
First posted: 2011-01-11
Enrollment: 30
Sex: MALE
Minimum age (years): 40
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: PREVENTION

Brief summary: Interactions between genes and environment, i.e. our inherited responses to environmental changes, may be crucial in the development of the common diseases. The investigators were the first to identify PPARG gene as risk gene for type 2 diabetes. The role of the Pro12Ala polymorphism in diabetes risk has also been verified in meta-analysis. However, this effect on seems to depend on intervention and age. In this study the effects of diets high with saturated fatty acids (SAFA) and polyunsaturated fatty acids (PUFA) are compared in subjects carrying either Pro12Pro or Ala12Ala genotype of the PPARG gene.

Aim of the study:

To test if subjects with Pro12Pro and Ala12Ala genotypes respond differentially to a diet supplemented with high saturated (SAFA) or polyunsaturated fat (PUFA).

Hypotheses:

1. Specific: Subjects with the Ala12Ala genotype will be more sensitive to dietary modification, and therefore respond more favorably to PUFA diet
2. More general: Dietary instructions individually tailored according to the genotype would allow better treatment of obesity and diabetes

Detailed description: Obesity and type 2 diabetes are increasing in all western countries, including Finland. Recent genome wide analyses have found \> 30 genes that contribute to either condition.. However, none of these genes explain \>5% of the disease risk and altogether they explain \< 10% of the total disease risk in cross-sectional studies. Therefore, diet and physical activity are still the major determinants of the risk, as demonstrated by our earlier intervention studies in order to find out the effect of different dietary modifications on glucose and lipid metabolism. More importantly, interactions between genes and environment, i.e. our inherited responses to environmental changes, may be crucial in the development of the common diseases. Unfortunately, gene-environment interaction can only be effectively investigated in intervention studies that are more expensive than cross-sectional population screenings. This leads to a lower sample size and reduced power to detect effects of minor alleles. Despite these limitations the investigators have been able to demonstrate gene-intervention interactions for several genes, including PPARG, in the Finnish Diabetes Prevention study. There is an urgent need for studies investigating effects of tailored diets in individuals selected based on their genotype. This will be the next essential step leading to improved dietary treatments guided by genetic information.

The investigators were the first to identify PPARG gene as risk gene for type 2 diabetes. The role of the Pro12Ala polymorphism in diabetes risk has also been verified in meta-analysis. However, this effect on seems to depend on intervention and age. Based on these findings the investigators created in collaboration with Johan Auwerx an Pro12Ala animal model that demonstrated a differential effect of dietary fat composition depending on the genotype. However, an important conclusive proof that subjects selected based on their Pro12Ala genotype would respond differently to specifically tailored diet modification is still needed.

In this study the effects of diets high with saturated fatty acids (SAFA) and polyunsaturated fatty acids (PUFA) are compared in subjects carrying either Pro12Pro or Ala12Ala genotype of the PPARG gene. As a primary endpoint the investigators expect insulin sensitivity to alter differently depending on the genotype. Additionally, a detailed characterization of energy, glucose and lipid metabolism will be performed. Because PPARG gene plays a central role in adipogenesis one of the aims of this study is to find new pathways, genes and gene clusters that are regulated by PPARG in humans.

Eligibility criteria: Inclusion Criteria:

* BMI \>20kg/m2 \<29kg/m2
* Pro12Pro and Ala12Ala genotypes of PPARG Pro12Ala polymorphism
* participation to METSIM-study (METabolic Syndrome in Men, currently \>10000 men included from the population living in Kuopio, principal investigator Markku Laakso)
* normoglycemia

Exclusion Criteria:

* type 2 diabetes
* other chronic diseases

Primary outcomes:
measure: insulin sensitivity
timeFrame: week 0
measure: insulin sensitivity
timeFrame: week 8
measure: insulin sensitivity
timeFrame: week 10
measure: insulin sensitivity
timeFrame: week 18
Secondary outcomes:
measure: peripheral blood mononuclear cell gene expression
timeFrame: week 8
measure: peripheral blood mononuclear cell gene expression
timeFrame: week 18
measure: serum lipids
timeFrame: week 8
measure: serum lipids
timeFrame: week 18
measure: inflammation
timeFrame: week 8
measure: inflammation
timeFrame: week 18
measure: energy expenditure
timeFrame: week 8
measure: energy expenditure
timeFrame: week 18
measure: insulin secretion
timeFrame: week 8
measure: insulin secretion
timeFrame: week 18
measure: adipose tissue gene expression
timeFrame: week 8
measure: adipose tissue gene expression
timeFrame: week 18
Other outcomes:
Locations:
city: Kuopio
country: Finland
facility: University of Eastern Finland
Study officials:
affiliation: University of Eastern Finland, Kuopio University Hospital
name: Jussi Pihlajamäki, Professor
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Eastern Finland
name: Ursula S Schwab, Clinical Lect, adjunct prof
role: STUDY_DIRECTOR
affiliation: Professor
name: Matti Uusitupa, Professor
role: STUDY_CHAIR
References: